Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Solid Tumor 1Rectal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Glioblastoma 1Gallbladder Neoplasms 1Colonic Neoplasms 1Breast Cancer Female 1

Interventions

Tamoxifen 2pembrolizumab 1Tretinoin 1Tocopherols 1Standard of Care 1Pentoxifylline 1Passive Cutaneous Anaphylaxis 1Mifepristone 1Metformin 1Isotretinoin 1Culture Techniques 1Cannabidiol 1Atorvastatin 1Anesthesia, General 1Anesthesia, Conduction 1Analgesia, Patient-Controlled 1Alitretinoin 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Cancer Female × Cannabidiol × Clear all
NCT05016349 2021-08-23

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Kafrelsheikh University

Phase 3 Unknown
160 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡